The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for routine administration in 2011. The purpose of this study was to uncover predictable commonalities amongst parents who chose to vaccinate their 11–17 year old sons against HPV.
We compiled data from a U.S. national sample of 779 parents with sons 11–17 years old using a web-based survey to gather information about behavioral and sociodemographic factors which predicted receipt of 1 or more HPV vaccine doses based on parental report. Predictors were first modeled individually for univariable associations. Significant predictors (p<0.10) were combined in a multivariable model.
In the adjusted model, independent predictors included receipt of flu vaccination, health insurance coverage and sexual health topic discussions with sons. Sons who had received a flu shot in the last two years more frequently received at least one dose of the vaccine (OR 1.82; 95% CI 1.45–2.26). Sons covered by private health insurance had decreased odds of HPV vaccination (OR 0.56 95% CI 0.37–0.83). Lastly, parents who had discussed sexual health topics with their sons were more likely to vaccinate (OR 1.61; 95% CI 1.37–1.89).
Male vaccination rates in the U.S. have increased, but males continue to be under-immunized. Utilization of health care is an important factor in HPV vaccine uptake; therefore, health care providers should use every contact as an opportunity to vaccinate. Communication about sexual health topics may provide a forum for parents and health care providers to have conversations about HPV vaccination as those more comfortable discussing these topics may also be more comfortable discussing HPV vaccination.
Citation: Taylor JL, Zimet GD, Donahue KL, Alexander AB, Shew ML, Stupiansky NW (2014) Vaccinating Sons against HPV: Results from a U.S. National Survey of Parents. PLoS ONE 9(12): e115154. https://doi.org/10.1371/journal.pone.0115154
Editor: Paul L. Reiter, The Ohio State University, United States of America
Received: July 22, 2014; Accepted: November 18, 2014; Published: December 26, 2014
Copyright: © 2014 Taylor et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files.
Funding: Support was provided by Merck MISP #38094 (Zimet, PI) [http://engagezone.merck.com/misp.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: This research was supported by an investigator initiated grant from Merck & Co. to Dr. Zimet (PI). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Dr. Stupiansky and Dr. Zimet are investigators on research projects funded by Merck & Co.’s Investigator Initiated Studies Program and Dr. Zimet was the recipient of an unrestricted program development grant for cervical cancer prevention funded by GSK. Dr. Shew is a Merck & Co. Clinical Investigator.
Human papillomavirus (HPV) is the most common sexually transmitted infection.  There are known causal associations between HPV and genital and anal cancers as well as genital warts and cancers of the head and neck.  The quadrivalent HPV vaccination protects against the most common HPV strains that cause HPV-related diseases: 6, 11, 16, and 18. It was approved for use in females in 2006 and, in 2009, it was approved for use in males ages 9 to 26. The recommendation for routine administration in males came in 2011.  Despite these recommendations, vaccination rates remain low. The most recent U.S National Immunization Survey-Teen (NIS-TEEN) data on adolescent vaccination indicates that 53.8% of females and 20.8% of males received at least one dose of HPV vaccine.  The NIS-TEEN collects data by list-assisted random-digit-dialing telephone survey followed by a mailed survey to children’s immunization providers .
The approval for use and consistent recommendations for HPV vaccination in males followed those for females, therefore, most research to date has concentrated on females. This research has focused largely on predictors of acceptability (i.e. attitudes surrounding vaccination and/or intention to vaccinate) and uptake (i.e. the actual act of getting the vaccine)  whereas most existing research regarding vaccination among males has focused solely on vaccine acceptability, largely because the recommendation to routinely vaccinate males is relatively recent.
Research published on females has suggested that parents who have previously vaccinated their adolescent daughters against HPV have more favorable attitudes toward HPV vaccine use in males.  Consistent with female vaccination data , , parents who consider religion more important are less willing to vaccinate their sons.  Parents who were more comfortable discussing new vaccines with their sons, and those with more liberal political views, were also more accepting of the HPV vaccine.  Additionally, it has been shown that males who have been vaccinated with other adolescent-timed vaccines, specifically the meningococcal vaccine, are more likely to have initiated the HPV vaccine , which is consistent with previous literature on female vaccination .
In one of the few studies published on HPV vaccine uptake in males, males whose mothers have received the influenza vaccine and pap smears are more likely to have been vaccinated.  Reiter et al showed that fathers are less likely than mothers to vaccinate and that health care provider (HCP) recommendation predicted vaccine uptake in males, similar to findings in adolescent females.  While vaccine uptake in males continues to increase, the percentage of males vaccinated remains low. There is currently insufficient data on predictors of male vaccine initiation. A recently published paper based on this dataset explored parents’ reported reasons for non-vaccination of sons.  The purpose of the current study was to examine parental beliefs, communication and vaccine-related health care utilization factors as potential predictors of HPV vaccination initiation of 11–17 year old sons. The importance of this study lies in the ability to discover why parents choose to vaccinate their sons.
We collected web-based survey data from a U.S. national sample of parents and legal guardians with sons 11–17 years of age (targeted age of the HPV vaccine). Using a survey research company (Survey Sampling International or SSI), data were drawn from U.S. adults in July and August of 2012. SSI maintains a national panel of adults in the U.S. and facilitates access to survey respondents for market and behavioral research. Invitations are sent at random to panel members fitting the study protocols. Those who volunteer are then entered into a lottery to win a monetary prize. Each panel member may participate in a maximum of four surveys annually. The respondents’ identities remain anonymous to study designers. Though the participants in this study were recruited nationally, they are not a nationally-representative sample.
For this study, emails were first sent to potential participants meeting inclusion criteria which consisted of having at least one son in the household between the ages of 11 and 17. Only one parent per household was asked to respond regarding only one son. Initially, 1322 panelists responded. 802 parents met eligibility criteria and agreed to participate in the study. There were 779 surveys completed with 758 of these respondents indicating the HPV vaccination status of their sons. If there was more than one son meeting inclusion criteria, parents were prompted to answer questions thinking of the youngest son in the designated age range. The nature of this study allowed for waiving of written informed consent which, along with study protocols, was approved by the Institutional Review Board at Indiana University-Purdue University, Indianapolis.
The survey used for this study was designed to gather information pertaining to parental demographics (race, age, gender, education, employment, etc.), religious service attendance, political views, son’s health insurance and health care utilization as well as recent influenza vaccination history and parental discussion of sexual health topics with their sons. These specific variables were chosen for their relationship with acceptance and initiation of HPV vaccination in prior research. , , , – For HPV vaccination status, parents were asked to indicate how many HPV shots their son had received, with responses choices of “none”, “one”, “two”, or “three”. For analysis a bivariate outcome variable was created: no doses vaccine versus one or more doses of vaccine.
Parents reported the frequency of religious service attendance to measure how involved they were in their particular religious organizations based on a 5-point response scale of “rarely or never” to “more than once a week.” Parents were asked to describe their political views as “conservative,” “liberal,” or “middle of the road” which have been shown previously to be associated with vaccine acceptability.  Son’s health insurance type was chosen by parents as either private or non-private, which included Medicaid, other state funded, self-pay, other and unknown. Parents reported on sons’ recent healthcare utilization (i.e., whether or not their son was taken to a doctor, nurse, or other health care provider in the last year) and the number of flu shots their son received in the last 2 years. Using a 4-point response format (“not at all” to “a great deal”), parents also reported on the amount of time they had spent in the last 6 months discussing sexual health topics, such as using condoms to prevent STDs, with their sons.
Correlations were examined among all potential independent variables to assess for collinerarity. Logistic regression models were used to examine the outcome of receipt of 1 or more doses of HPV vaccine. Univariable models examined each of the behavioral and sociodemographic predictors with HPV vaccination outcome. Predictors with significant univariable associations (defined as p<0.10) were then included in a multivariable, adjusted model. All analyses were performed using SPSS 21.  Please refer to the supplemental material for data pertinent to this model (S1 Manuscript).
Both male and female parents completed the survey and were similarly represented at 48.5% and 51.5%, respectively. The mean age of parents completing the survey was 42.2 years (Standard Deviation = 11.5). Most parents were non-Hispanic White (73.8%), followed by non-Hispanic Black (10%), Hispanic (9.8%), and other race/ethnicity (6.5%). Sons had a mean age of 13.8 years (Standard Deviation = 2.0). The majority of sons (88.5%) had seen an HCP in the last year, and 63.8% had received at least one flu shot in the last two years. See Table 1 for a complete description of the sample. Of the 758 parents who provided information about their son’s HPV vaccination status, 162 (21.4%) indicated that one or more doses of the vaccine had been administered, 73 (9.7%) indicated that two or more doses of the vaccine had been administered and 24 (3.2%) indicated that 3 doses had been administered.
Table 2 shows the correlations among all predictors. As parent’s age increased, their political views became more conservative (r = −0.12, p<0.05), their religious service attendance increased (r = 0.09, p<0.05), and their sons were more likely to have private insurance (r = 0.07, p<0.05). The more liberal parental political views, the more likely they were to speak to their son regarding sexual health (r = 0.07, p<0.05). The more conservative parental political views, the more likely sons were to have private insurance (r = −0.10, p<0.05). As son’s age increased there was an attendant increase in sexual health discussions with the parent (r = 0.29, p<0.05) but a decrease in HCP visits (r = −0.11, p<0.05). These correlations, though statistically significant, all reflected small effect sizes, suggesting no issues of multicollinearity in multivariable analyses.
Univariable logistic regression analyses indicated that vaccine initiation was modestly, but inversely related to parental age (OR 0.98; 95% CI 0.96–0.99). Black (OR 2.08; 95% CI 1.23–3.53) or Hispanic (OR 2.61; 95% CI 1.54–4.42) parents were more likely than White parents to initiate vaccination. Sons who were evaluated by health care providers sometime in the last year more frequently received at least one dose of the vaccine (OR 2.22; 95% CI 1.12–4.40) as did those who had received a flu shot in the last two years (OR 1.82; 95% CI 1.45–2.26). Son’s with private health insurance were less likely to have initiated vaccination than those without private insurance (OR 0.55; 95% CI 0.38–0.79). There was an association between more reported discussion of sexual health topics and greater likelihood of first dose uptake (OR 1.61; 95% CI 1.37–1.89). Parent gender, religiosity (measured by religious service attendance), and sons’ age were not significant predictors of HPV vaccine initiation. Multivariable logistic regression was performed to include all variables in the model which were significant at p<0.10 in the univariable models. With the exception of parental age and political views as well as son’s visit to an HCP, all significant bivariate predictors remained independent predictors of HPV vaccine initiation in the adjusted, multivariable model (see Table 3).
The adolescent male vaccination rate reported by this national sample of parents in 2012 was comparable to the 2012 NIS-TEEN data for males and females ages 13 to 17.  Although this set of findings indicates a marked increase from the initiation of male vaccination in 2011, it nonetheless points to ongoing under-immunization of the vaccine in males. Hispanic ethnicity of the parent, as well as health care provider visit in the prior year by the son, number of flu shots received by the son, son’s health insurance status, and frequency of discussion about sexual health were all associated with HPV vaccine initiation.
Parent and adolescent demographics have been shown in previous research to predict uptake of the HPV vaccine. Both conservative political views  and increased religious service attendance (religiosity) ,  were shown to predict decreased vaccine uptake in females. In this study, a correlation was found between increasing parent age and both conservative political views and religiosity; however, none of these were associated with vaccine uptake. Son’s age was not a predictor of vaccination uptake, a finding consistent with the 2012 NIS-TEEN data on males.  In contrast, 2012 NIS-TEEN findings indicate a steady increase in female HPV vaccination rates from 13 through 17 years of age.  These findings may indicate that parents are more comfortable with vaccinating young adolescent sons than young adolescent daughters, perhaps reflecting, a sexual double standard, which is a well-established societal phenomenon.  Parents may be more willing to vaccinate young males if the idea of emerging male sexuality is less discomforting than emerging female sexuality. It is also possible that HCPs are influenced by the same double standard, as research suggests that frequency of HCP recommendation for HPV vaccine for females also increases with patient age.  As rates of male vaccination increase, it will be important to assess whether these differences persist, as they have implications for gender-based health disparities. Past research has suggested that sexual double standards have had a negative effect on women’s sexual health .
Consistent with our results, previous studies have found that recent influenza vaccination is related to both acceptability and initiation of HPV vaccination. ,  Both influenza and HPV vaccination rates are relatively low compared to other childhood/adolescent vaccines ,  suggesting that both may suffer from vaccine hesitancy on the part of parents and HCPs.
Both influenza and HPV are non-required vaccines, and parents often decline them for a multitude of reasons. , ,  Published research suggests that HCP recommendation and strength of recommendation are associated with increased HPV vaccine uptake. , ,  HCPs who strongly recommend all vaccines, not just those required for school, may be increasing HPV vaccination rates within their practice. Future investigation examining the basis for the relationship between influenza vaccine and HPV vaccination may help to clarify the nature of this association, which in turn may have implications for clinical practice. We also found that those sons who have private health insurance are less likely than those without private health insurance to have initiated vaccination. Previous publications representing data on both males and females suggest that having public insurance is related to increased HPV vaccine initiation which may be related to public vaccine programs such as the Vaccines for Children Program , .
Lastly, it has been proposed that parents who are comfortable discussing sexual health topics with their sons are more likely to engage in conversation with them regarding HPV vaccination.  Since parents are, in the end, the consenting party for those sons under age 18, this comfort level with sexual health discussion may be a vital key to improving vaccination rates. ,  Sons may have knowledge, or specific beliefs, about HPV vaccination. By encouraging parents and teens to have open discussions surrounding sexual health, HCPs may provide a forum for discussion surrounding prevention of sexually transmitted infections, and son’s may feel more comfortable expressing their beliefs about HPV vaccination.
As in all research, there were limitations to this study. The survey participants represented a national sample of parents of sons; however, the sample was not nationally representative, and vaccination status was based on parental report which has variable accuracy.  These issues can raise concerns regarding generalizability. However, as noted above, the most recent NIS-TEEN data on initiation of HPV vaccine in males is similar to the data we obtained, suggesting that our sample did not deviate substantially from the nationally representative NIS-TEEN sample with respect to vaccination rates .
This research shows sons who were exposed to healthcare services, specifically those who had received flu shots, had an increased rate of vaccine initiation. Both the Society for Adolescent Health and Medicine , and the American Academy of Pediatrics Bright Futures initiative  support routine provision of all recommended vaccines for adolescents, including influenza vaccination. Our findings suggest that HPV vaccination rates might increase by following the practice of routinely recommending all adolescent vaccines. We would encourage further research to examine the relationship between HCP recommendation and receipt of these routine but non-required vaccinations. The possibility of a sexual double standard is intriguing and deserves further investigation.
Vaccinating sons against HPV: Results from a U.S. national study of parents.
Poster Symposium, Presented by Jaime L Taylor, DO.
Society for Adolescent Health and Medicine Annual Meeting, March 24, 2014.
Conceived and designed the experiments: GDZ NWS MLS. Performed the experiments: GDZ NWS. Analyzed the data: JLT GDZ NWS KLD. Contributed reagents/materials/analysis tools: MLS GDZ NWS. Contributed to the writing of the manuscript: JLT GDZ ABA MLS KLD NWS.
- 1. Centers for Disease Control and Prevention (2014) Human Papillomavirus. Available: http://www.cdc.gov/std/hpv/default.htm. Accessed 2014 Sep 4.
- 2. Chaturvedi AK (2010) Beyond cervical cancer: burden of other HPV-related cancers among men and women. Journal of Adolescent Health. 46(4):S20–S26.
- 3. Centers for Disease Control and Prevention (2011) Recommendations on the use of quadrivalent human papillomavirus vaccine in males – Advisory Committee on Immunization Practices (ACIP). MMWR: 1705–1708.
- 4. Centers for Disease Control and Prevention (2013) National and state vaccination coverage among adolescents aged 13–17 years–United States, 2012. MMWR Morb Mortal Wkly Rep 62(34):685–93.
- 5. National Immunization Survey (2014) Available: http://www.cdc.gov/nchs/nis.htm. Accessed 2014 Apr 2.
- 6. Stupiansky NW, Zimet GD (2013) STD Vaccine Acceptability in Sexually Transmitted Diseases. Adademic Press: London. 251–269.
- 7. Reiter PL, McRee AL, Gottlieb SL, Brewer NT (2010) HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 28(38):6292–7.
- 8. Stupiansky NW, Rosenthal SL, Wiehe SE, Zimet GD (2010) Human papillomavirus vaccine acceptability among a national sample of adult women in the USA. Sex Health. 7(3):304–9.
- 9. Barnack JL, Reddy DM, Swain C (2010) Predictors of parents’ willingness to vaccinate for human papillomavirus and physicians’ intentions to recommend the vaccine. Women’s Health Issues. 20(1):28–34.
- 10. Reiter PL, Brewer NT (2011) Hepatitis B vaccination among a national sample of gay and bisexual men. Sex Transm Dis. 38(3):235–8.
- 11. Gilkey MB, Moss JL, McRee AL, Brewe NT (2012) Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine. 30 (40):5928–2934.
- 12. Etter DJ, Zimet GD, Rickert VI (2012) Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol. 24(5):305–310.
- 13. Hechter RC, Chao C, Sy LS, Ackerson BK, Slezak JM, et al. (2013) Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections. Am J Public Health. 103(9):e63–68.
- 14. Reiter PL, McRee AL, Pepper JK, Gilkey MB, Galbraith KV, et al. (2013) Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 103(8):1419–1427.
- 15. Donahue KL, Stupiansky NW, Alexander AB, Zimet GD (2014) Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons. Vaccine. 32 (30):3883–3885.
- 16. Chao C, Velicer C, Slezak JM, Jacobsen SJ (2010) Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology. 171(3):357–367.
- 17. Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML (2013) A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 17(5):879–85.
- 18. Holman DM, Benard V, Roland KB, Watson M, Liddon N, et al. (2014) Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatr. 168(1):76–82.
- 19. Hendry M, Lewis R, Clements A, Damrey S, Wilkonson C (2013) “HPV? Never heard of it!”: a systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination. Vaccine. 31(45):5152–67.
- 20. IBM Corporation (2012) SPSS Statistics for Windows. Armonk (New York). IBM Corp.
- 21. Crawford M, Popp D (2003) Sexual double standards: a review and methodological critique of two decades of research. J Sex Res. 40(1):13–26.
- 22. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, et al. (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine. 29(47):8634–8641.
- 23. Centers for Disease Control and Prevetnion (2013) Flu Vaccination Coverage. Available: http://www.cdc.gov/flu/fluvaxview/coverage-1213estimates.htm. Accessed 2014 Mar 7.
- 24. Daley MF, Crane LA, Chandramouli V, Beaty BL, Barrow J (2007) Misperceptions about influenza vaccination among parents of healthy young children. Clinical pediatrics 46 (5):408–417.
- 25. Humiston SG, Lerner EB, Hepworth E, Blythe T, Goepp JG (2005) Parent opinions about universal influenza vaccination for infants and toddlers. Archives of pediatrics & adolescent medicine 159 (2):108–112.
- 26. Laz TH, Rahman M, Berenson AB (2013) Human papillomavirus vaccine uptake among 9–17 year old males in the United States: The National Health Interview Survey, 2010. Human vaccines & immunotherapeutics. 9(4):874.
- 27. Dempsey A, Cohn L, Dalton V, Ruffin M (2010) Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 28(4):989–995.
- 28. Alexander AB, Stupiansky NW, Ott MA, Herbernick D, Reece M, et al. (2012) Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr. 12(1):192.
- 29. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS (2009) Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 69(3):475–80.
- 30. Stupiansky NW, Zimet GD, Cummings T, Fortenberry JD, Shew M (2012) Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health. 50(1):103–105.
- 31. Middleman AB, Rosenthal SL, Rickert VI, Neinstein L, Fishbein DB, et al. (2006) Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 38(3):321–327.
- 32. Hagan JF, Shaw JS, Duncan P (2008) Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, AAP, Pediatrics, Editor. Elk Grove Village, IL.